Clinical Trials List
2020-12-01 - 2025-08-31
Phase II/III
Recruiting5
Terminated1
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 胡力予 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YI-LING CHIEN Division of Psychiatry
- Chen-Chung Liu Division of Psychiatry
- CHIH-MIN LIU Division of Psychiatry
- Tzung-Jeng Hwang Division of Psychiatry
- YI-TING LIN Division of Psychiatry
- 謝明憲 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊緯聖 Division of Psychiatry
- 周亞欣 Division of Psychiatry
- 林皇利 Division of Psychiatry
- 林式穀 Division of Psychiatry
- Chia-Yi Liu Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳易隆 Division of Psychiatry
- Po-Yu Chen Division of Psychiatry
- 林式穀 Division of Psychiatry
- 李宛臻 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YI-TING LIN Division of Psychiatry
- 謝明憲 Division of Psychiatry
- Chen-Chung Liu Division of Psychiatry
- CHIH-MIN LIU Division of Psychiatry
- YI-LING CHIEN Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
500 participants
